Leveraging halogenenation for selective C-H activation & DIVERSIFICATION
With our powerful combination of synthetic biology and synthetic chemistry we are uniquely placed to assist partners with fragment and complex molecule vectorisation, diversification and the discovery and development of new, highly targeted drugs.
We use in house know-how and our patented discovery platform to find powerful natural tools for C-X bond formation, the gateway to almost any diversification. Our approach levers over 3.5 billion years of natural evolution to provide precise & sustainable enzymatic solutions for chemical transformations.
Using cutting edge synthetic biology tools, we have assembled and patented a large palette of diverse enzymes to both accelerate your R+D and to make your manufacturing process cheaper, safer and more sustainable.
We are experts in biotransformations, providing and developing enzymatic solutions for selective chemistry for both your R+D and manufacturing needs.
We discover and develop bespoke enzymatic solutions to meet your R+D and manufacturing needs, achieving regioselective control that is not possible using synthetic chemistry processes alone.
Blending synthetic chemistry and synthetic biology presents a powerful opportunity for precision molecule editing and value creation. Our tools enable late-stage functionalisation.
Patented technology providing a powerful tool for drug discovery
X-Genix has patented halogenase discovery platform technology. Our IP position is strengthened by considerable in-house know-how and a strong, growing and relevant IP pipeline. We have a broad platform technology from which we utilise an IP based business model approach to deliver value. We will continue to control and develop the platform technology and will work with customers to adapt that technology to their specific product needs offering a bespoke solution.